Insmed Incorporated
INSMNASDAQHealthcare● Active
$94.17
$-0.05(-0.05%)
Market Cap$20.4B
P/E Ratio—
52W High$212.75
52W Low$86
Insmed Incorporated (INSM) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · INSM · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($1.28B) | ($0.91B) | ($0.75B) | ($0.48B) | ($0.43B) |
| Depreciation & Amort. | $0.02B | $0.01B | $0.01B | $0.01B | $0.01B |
| Stock-Based Comp. | $0.15B | $0.10B | $0.07B | $0.06B | $0.05B |
| Change in Working Capital | ($0.08B) | ($0.00B) | ($0.04B) | $0.01B | ($0.06B) |
| Net Cash from Operations | ($0.94B) | ($0.68B) | ($0.54B) | ($0.40B) | ($0.36B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.03B) | ($0.02B) | ($0.01B) | ($0.01B) | ($0.01B) |
| Purchases of Investments | ($2.09B) | ($1.58B) | ($0.59B) | ($0.10B) | ($0.05B) |
| Sales of Investments | $2.09B | $1.02B | $0.38B | $0.07B | $0.06B |
| Net Cash from Investing | ($0.06B) | ($0.58B) | ($0.22B) | ($0.03B) | ($0.06B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.00B) | $0.15B | ($0.00B) | $0.35B | $0.34B |
| Net Cash from Financing | $0.95B | $1.34B | $0.17B | $0.79B | $0.61B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.97B) | ($0.71B) | ($0.55B) | ($0.41B) | ($0.37B) |
| FCF Margin %(computed) | -159.55% | -194.06% | -180.05% | -167.23% | -196.64% |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Insmed Incorporated data
About Insmed Incorporated (INSM) Cash Flow Statement
Insmed Incorporated generated operating cash flow of ($0.94B) and free cash flow of ($0.97B) for 2025 — a FCF margin of -159.55%. Capital expenditure was ($0.03B).
Frequently asked questions
INSM · 4 questionsInsmed Incorporated generated free cash flow of ($0.97B) for 2025, down 37.1% year-over-year.
INSM free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10